Prevent Cancer Foundation awards eight new research grants
FOU DIFFUSION IMMÉDIATE
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Alexandrie, Virginie – La Fondation Prévenir le Cancer® is pleased to announce funding for eight scientists who are researching cancer prevention and early detection. Each scientist has been awarded $100,000 for two years. Areas of focus include the blood, breast, colon, lung and skin (including melanoma).
Pour honorer l'héritage de l'ancien membre du conseil d'administration de la Fondation, Le député Victor « Vic » Fazio—who died of melanoma in March 2022—a $100,000 melanoma research grant was awarded in this year’s cycle.
Listed below are the 2023 research grantees. Click here for more detailed information about their projects.
Bénéficiaire: Francisco Cartujano, M.D.
Titre du projet: Advancing Lung Cancer Screening Among Latinos One Text at a Time
Prix nommé : Richard C. Devereaux Outstanding Young Investigator Award
Position: Maître assistant
Institution: University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, N.Y.
Lung cancer remains the number one cause of cancer-related death among Latinos. Although lung cancer screening has been shown to reduce deaths, uptake among Latinos remains low. This project aims to develop and pilot test a text messaging program to increase the enrollment of lung cancer screening among Latinos.
Bénéficiaire: Brandon Gheller, Ph.D.
Titre du projet: Dietary Intervention for Clonal Hematopoiesis, Myelodysplasia and Leukemia
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Research Fellow
Institution: Boston Children’s Hospital, Boston, Mass.
Clonal hematopoiesis is a condition where genetic mutations found in the blood predict cancer initiation and severity. This project aims to identify dietary interventions that can be applied safely for long periods of time in this pre-cancerous state to prevent cancer initiation.
Bénéficiaire: Maayan Levy, Ph.D.
Titre du projet: Designing Metabolite-Based Prevention in Lynch Syndrome
Prix nommé : Stohlman Family Grant in memory of Richard Stohlman and Margaret Weigand
Position: Researcher
Institution: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pun.
Despite the genetic predisposition to colorectal cancer in patients with Lynch syndrome, the age of onset and rate of progression is highly variable among patients, indicating a critical role for modifiable environmental factors, including diet, in disease manifestation. This study will serve as the steppingstone for larger follow-up trials in individuals with Lynch Syndrome and beyond. It is the hope that this study will establish a new, low-cost and widely accessible prevention method for colorectal cancer.
Bénéficiaire: Veronica Rotemberg, M.D., Ph.D.
Titre du projet: Quantifying the jempact of Skin Tone on Diagnostic Prediction
Prix nommé : Fonds commémoratif Vic Fazio
Position: Director of the Tow Foundation Informatics Program in the Dermatology Service
Institution: Memorial Sloan Kettering Cancer Center, New York, N.Oui.
Artificial intelligence has immense potential to improve access to expert-level melanoma screening in low-resource areas and enhance specificity of nonexperts. This project will evaluate algorithms and the largest training repository against potential sources of bias, such as skin tone.
Bénéficiaire: Caner Saygin, M.D.
Titre du projet: Dissecting the Evolution of Clonal Hematopoiesis to Prevent UNcute Leukemias
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Fellow
Institution: University of Chicago, Chicago, jell.
Clonal hematopoiesis (CH) is a pre-malignant state that can be detected in blood cells of a person years before the diagnosis of acute leukemia. By understanding the mechanisms by which CH causes leukemia, this project aims to develop new strategies to predict the risk and prevent leukemia before it happens.
Bénéficiaire: Srividya Swaminathan, Ph.D.
Titre du projet: Targeting the Long jesoform of the Prolactin Receptor to Prevent B-Lymphomas
Prix nommé : Congressional Families Program: Tribute to The Honorable Vic Fazio
Position: Assistant Professor, Systems Biology
Institution: Beckman Research Institute of the City of Hope, Duarte, Calif.
Children and adults with certain kinds of autoimmune diseases are at high risk of developing aggressive B-cell lymphoma. This study seeks a new strategy for the early diagnosis and prevention of lymphoma among this vulnerable population.
Bénéficiaire: Ester Villalonga Olives, Ph.D.
Titre du projet: Adaptation of Project HEAL for Hispanic/Latino jemmigrants
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Maître assistant
Institution: University of Maryland, Baltimore, Md.
Late-stage cancer has been linked to lower survival rates. Immigrant Hispanics/Latinos tend to be diagnosed at advanced stages, which can contribute to their disproportional rate of cancer-related mortality. This intervention aims to increase cancer knowledge and screening intention among this population.
Bénéficiaire: Michelle Williams, Ph.D., M.S.P.H., M.P.H.
Titre du projet: A Multicomponent Lung Cancer Screening Awareness mHealth Intervention
Prix nommé : The Shure Family Charitable Foundation
Position: Maître assistant
Institution: George Mason University, Fairfax, Va.
Experts suggest that yearly lung cancer screening is one of the most effective ways to decrease lung cancer mortality rates. The evidence-based lung cancer education program of this project is focused on using mobile health technology to promote participation in lung cancer screening among high-risk populations.
To view all past funded research grant and fellowship projects driving these key advancements in cancer prevention and early detection, explore the Prevent Cancer Foundation’s Award Database.
###
À propos de la Fondation Prévenir le Cancer®
La Fondation Prévenir le Cancer® est les seuls États-Unis-basé organisation à but non lucratif uniquement dédié à cancer prévention et précoce détection. Par la recherche, l'éducation, sensibilisation et plaidoyer, nous avons aidé d’innombrables personnes à éviter un diagnostic de cancer ou à détecter leur cancer suffisamment tôt pour être traité avec succès. Nous sommes conduits par une vision d'un monde où le cancer est évitable, détectable et battable pour tous.
La Fondation se mobilise pour relever le défi de réduire les décès par cancer de 40% d'ici 2035. Pour y parvenir, nous sommes s'est engagé à investir $20 millions dans des technologies innovantes permettant de détecter le cancer à un stade précoce et de progresser multi-dépistage du cancer, $10 millions pour élargir l'accès au dépistage du cancer et à la vaccination médicalement communautés mal desservies et $10 millions pour informer le public sur les options de dépistage et de vaccination.
Pour plus d'informations, s'il vous plaît visitez www.preventcancer.org.